Payer Roadblocks in Pediatric Atopic Dermatitis Care
Expensive, newer therapies and a lack of pediatric data are roadblocks to advancing treatment for pediatric atopic dermatitis, according to Lawrence Eichenfield, M.D., chief of pediatric and adolescent dermatology at Rady Children’s Hospital, San Diego.
“It seems to be that roadblocks or speed bumps are being put in the way for newer therapies,”
Newer therapies include non-steroidal agents, which offer longer treatment windows with fewer side effects than topical steroids, which can cause skin thinning, easy bruising and redness.
Eichenfield also mentioned the lack of pediatric data, which stalls approvals.
Author's summary: Roadblocks hinder pediatric atopic dermatitis treatment advancements.
More News
- Australian government bans Dutch volleyball rapist
- Australian government bans Dutch volleyball rapist
- Commentary: From Latter-day Saint to Catholic saint? The incredible spiritual journey of a mystical Utah native.
- Regional Educator Network shows off programs in Pendleton - East Oregonian
- Feature Grade Blackbutt from Big River Group | ArchitectureAu